Stock Analysis

Asahi Intecc Second Quarter 2025 Earnings: Beats Expectations

TSE:7747
Source: Shutterstock

Asahi Intecc (TSE:7747) Second Quarter 2025 Results

Key Financial Results

  • Revenue: JP¥30.3b (up 18% from 2Q 2024).
  • Net income: JP¥5.48b (up 46% from 2Q 2024).
  • Profit margin: 18% (up from 15% in 2Q 2024). The increase in margin was driven by higher revenue.
  • EPS: JP¥20.16 (up from JP¥13.78 in 2Q 2024).
earnings-and-revenue-growth
TSE:7747 Earnings and Revenue Growth February 17th 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

Asahi Intecc Revenues and Earnings Beat Expectations

Revenue exceeded analyst estimates by 6.0%. Earnings per share (EPS) also surpassed analyst estimates by 9.8%.

Looking ahead, revenue is forecast to grow 8.2% p.a. on average during the next 3 years, compared to a 6.9% growth forecast for the Medical Equipment industry in Japan.

Performance of the Japanese Medical Equipment industry.

The company's share price is broadly unchanged from a week ago.

Balance Sheet Analysis

Just as investors must consider earnings, it is also important to take into account the strength of a company's balance sheet. See our latest analysis on Asahi Intecc's balance sheet health.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About TSE:7747

Asahi Intecc

Engages in the development, manufacture, and sale of medical devices in Japan, the United States, Europe, China, and internationally.

Flawless balance sheet with solid track record.